Pages that link to "Q73002699"
Jump to navigation
Jump to search
The following pages link to The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats (Q73002699):
Displaying 50 items.
- The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats (Q24603020) (← links)
- Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex (Q24612550) (← links)
- The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats (Q24631402) (← links)
- Methamphetamine-associated psychosis (Q24632172) (← links)
- Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects (Q24814115) (← links)
- Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment (Q26852047) (← links)
- Agents in development for the management of cocaine abuse (Q28270110) (← links)
- Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects (Q28276986) (← links)
- An animal model of emotional blunting in schizophrenia (Q28471824) (← links)
- Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? (Q30379983) (← links)
- Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats (Q30391868) (← links)
- Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence (Q30414307) (← links)
- Allosteric modulation of metabotropic glutamate receptors (Q30448534) (← links)
- Targeting glutamate synapses in schizophrenia (Q30460392) (← links)
- NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia. (Q30465008) (← links)
- Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. (Q30466262) (← links)
- Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia (Q30473410) (← links)
- Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors (Q30491856) (← links)
- 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice (Q33225041) (← links)
- Targeting metabotropic glutamate receptors for novel treatments of schizophrenia (Q33604654) (← links)
- Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence (Q33788180) (← links)
- The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats (Q33934716) (← links)
- Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats (Q33936354) (← links)
- Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion (Q34197072) (← links)
- Development of allosteric modulators of GPCRs for treatment of CNS disorders (Q34373958) (← links)
- Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). (Q34395427) (← links)
- The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice. (Q34427453) (← links)
- Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics (Q34451402) (← links)
- Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor (Q34463460) (← links)
- Ketamine and phencyclidine: the good, the bad and the unexpected (Q34480719) (← links)
- mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia (Q34513221) (← links)
- An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats (Q34513500) (← links)
- Neuropharmacology of N,N-dimethyltryptamine (Q34524116) (← links)
- In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders (Q34612242) (← links)
- From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment (Q34632695) (← links)
- Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons (Q34675038) (← links)
- The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. (Q34725251) (← links)
- Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders. (Q34917667) (← links)
- Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain (Q35080459) (← links)
- The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome (Q35341956) (← links)
- (-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking (Q35478617) (← links)
- Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence (Q35592069) (← links)
- The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex (Q35623415) (← links)
- Translating glutamate: from pathophysiology to treatment (Q35739457) (← links)
- The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task (Q35740788) (← links)
- Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia (Q35810054) (← links)
- The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances. (Q35952221) (← links)
- Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia (Q36052391) (← links)
- Ionotropic and metabotropic glutamate receptor structure and pharmacology (Q36054635) (← links)
- Effects of metabotropic glutamate receptor ligands on male sexual behavior in rats (Q36472772) (← links)